Testing effectiveness (Phase 2)Study completedNCT03512249
What this trial is testing
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
Who this might be right for
Tuberculosis, Pulmonary
International AIDS Vaccine Initiative 831
Showing 2 of 2 results